AAAAAA

   
Results: 1-25 | 26-35
Results: 1-25/35
Increase and plateau of CD4 T-cell counts in the 3 1/2 years after initiation of potent antiretroviral therapy
Authors: Tarwater, PM Margolick, JB Jin, JH Phair, JP Detels, R Rinaldo, C Giorgi, J Munoz, A
Citation: Pm. Tarwater et al., Increase and plateau of CD4 T-cell counts in the 3 1/2 years after initiation of potent antiretroviral therapy, J ACQ IMM D, 27(2), 2001, pp. 168-175
Determinants of heterogeneous adherence to HIV-antiretroviral therapies inthe multicenter AIDS cohort study
Authors: Kleeberger, CA Phair, JP Strathdee, SA Detels, R Kingsley, L Jacobson, LP
Citation: Ca. Kleeberger et al., Determinants of heterogeneous adherence to HIV-antiretroviral therapies inthe multicenter AIDS cohort study, J ACQ IMM D, 26(1), 2001, pp. 82-92
Risk factors for HIV-1 seropositivity in drug users under 30 years old in Haiphong, Vietnam
Authors: Nguyen, TA Hoang, LT Pham, VQ Detels, R
Citation: Ta. Nguyen et al., Risk factors for HIV-1 seropositivity in drug users under 30 years old in Haiphong, Vietnam, ADDICTION, 96(3), 2001, pp. 405-413
Therapy naivete in the era of patent antiretroviral therapy
Authors: Jacobson, LP Gore, ME Strathdee, SA Phair, JP Riddler, S Detels, R
Citation: Lp. Jacobson et al., Therapy naivete in the era of patent antiretroviral therapy, J CLIN EPID, 54(2), 2001, pp. 149-156
Thrush and fever as markers of immune competence in the era of highly active antiretroviral therapy
Authors: Skolasky, RL Phair, J Detels, R Riddler, S Margolick, J Jacobson, LP
Citation: Rl. Skolasky et al., Thrush and fever as markers of immune competence in the era of highly active antiretroviral therapy, AIDS RES H, 17(14), 2001, pp. 1311-1316
Longitudinal patterns of HIV type 1 RNA among individuals with late disease progression
Authors: Gange, SJ Mellors, JW Lau, B Detels, R Phair, JP Munoz, A Margolick, JB
Citation: Sj. Gange et al., Longitudinal patterns of HIV type 1 RNA among individuals with late disease progression, AIDS RES H, 17(13), 2001, pp. 1223-1229
Immunologic and virologic response to highly active antiretroviral therapyin the Multicenter AIDS Cohort Study
Authors: Yamashita, TE Phair, JP Munoz, A Margolick, JB Detels, R O'Brien, SJ Mellors, JW Wolinsky, SM Jacobson, LP
Citation: Te. Yamashita et al., Immunologic and virologic response to highly active antiretroviral therapyin the Multicenter AIDS Cohort Study, AIDS, 15(6), 2001, pp. 735-746
Effectiveness of potent antiretroviral therapies on the incidence of opportunistic infections before and after AIDS diagnosis
Authors: Detels, R Tarwater, P Phair, JP Margolick, J Riddler, SA Munoz, A
Citation: R. Detels et al., Effectiveness of potent antiretroviral therapies on the incidence of opportunistic infections before and after AIDS diagnosis, AIDS, 15(3), 2001, pp. 347-355
Prevalence of HIV infection among former commercial plasma donors in ruraleastern China
Authors: Wu, ZY Rou, KM Detels, R
Citation: Zy. Wu et al., Prevalence of HIV infection among former commercial plasma donors in ruraleastern China, HEAL POL PL, 16(1), 2001, pp. 41-46
Cross-sectional study of sexual behaviour and knowledge about HIV among urban, rural, and minority residents in Viet Nam
Authors: Bui, TD Pham, CK Pham, TH Hoang, LT Nguyen, TV Vu, TQ Detels, R
Citation: Td. Bui et al., Cross-sectional study of sexual behaviour and knowledge about HIV among urban, rural, and minority residents in Viet Nam, B WHO, 79(1), 2001, pp. 15-21
Methods to assess population effectiveness of therapies in human immunodeficiency virus incident and prevalent cohorts
Authors: Tarwater, PM Mellors, J Gore, ME Margolick, JB Phair, J Detels, R Munoz, A
Citation: Pm. Tarwater et al., Methods to assess population effectiveness of therapies in human immunodeficiency virus incident and prevalent cohorts, AM J EPIDEM, 154(7), 2001, pp. 675-681
HIV disease in ethnic minorities: Implications of racial/ethnic differences in disease susceptibility and drug dosage response for HIV infection and treatment
Authors: Mays, VM So, BT Cochran, SD Detels, R Benjamin, R Allen, E Kwon, S
Citation: Vm. Mays et al., HIV disease in ethnic minorities: Implications of racial/ethnic differences in disease susceptibility and drug dosage response for HIV infection and treatment, HANDBOOK OF HEALTH PSYCHOLOGY, 2001, pp. 801-816
Association of race and gender with HIV-1 RNA levels and immunologic progression
Authors: Anastos, K Gange, SJ Lau, B Weiser, B Detels, R Giorgi, JV Margolick, JB Cohen, M Phair, J Melnick, S Rinaldo, CR Kovacs, A Levine, A Landesman, S Young, M Munoz, A Greenblatt, RM
Citation: K. Anastos et al., Association of race and gender with HIV-1 RNA levels and immunologic progression, J ACQ IMM D, 24(3), 2000, pp. 218-226
Causal pathways for CCR5 genotype and HIV progression
Authors: Taylor, JMG Wang, Y Ahdieh, L Chmiel, JS Detels, R Giorgi, JV Kaslow, R Kingsley, L Margolick, J
Citation: Jmg. Taylor et al., Causal pathways for CCR5 genotype and HIV progression, J ACQ IMM D, 23(2), 2000, pp. 160-171
Prevalence of HCV & HBV infection amongst HIV seropositive intravenous drug users & their non-injecting wives in Manipur, India
Authors: Saha, MK Chakrabarti, S Panda, S Naik, TN Manna, B Chatterjee, A Detels, R Bhattacharya, SK
Citation: Mk. Saha et al., Prevalence of HCV & HBV infection amongst HIV seropositive intravenous drug users & their non-injecting wives in Manipur, India, I J MED RES, 111, 2000, pp. 37-39
HIV-1 subtypes in injecting drug users & their non-injecting wives in Manipur, India
Authors: Chakrabarti, S Panda, S Chatterjee, A Sarkar, S Manna, B Singh, NB Naik, TN Detels, R Bhattacharya, SK
Citation: S. Chakrabarti et al., HIV-1 subtypes in injecting drug users & their non-injecting wives in Manipur, India, I J MED RES, 111, 2000, pp. 189-194
Transmission of HIV from injecting drug users to their wives in India
Authors: Panda, S Chatterjee, A Bhattacharya, SK Manna, B Singh, PN Sarkar, S Naik, TN Chakrabarti, S Detels, R
Citation: S. Panda et al., Transmission of HIV from injecting drug users to their wives in India, INT J STD A, 11(7), 2000, pp. 468-473
AIDS onset at high CD4(+) cell levels is associated with high HIV load
Authors: Hennessey, KA Giorgi, JV Kaplan, AH Visscher, BR Gange, S Margolick, JB Riddler, S Phair, J Detels, R
Citation: Ka. Hennessey et al., AIDS onset at high CD4(+) cell levels is associated with high HIV load, AIDS RES H, 16(2), 2000, pp. 103-107
Evidence that anoreceptive intercourse with ejaculate exposure is associated with rapid CD4 cell loss
Authors: Wiley, DJ Visscher, BR Grosser, S Hoover, DR Day, R Gange, S Chmiel, JS Mitsuyasu, R Detels, R
Citation: Dj. Wiley et al., Evidence that anoreceptive intercourse with ejaculate exposure is associated with rapid CD4 cell loss, AIDS, 14(6), 2000, pp. 707-715
Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study
Authors: McDermott, DH Beecroft, MJ Kleeberger, CA Al-Sharif, EM Ollier, WER Zimmerman, PA Boatin, BA Leitman, SF Detels, R Hajeer, AH Murphy, PM
Citation: Dh. Mcdermott et al., Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study, AIDS, 14(17), 2000, pp. 2671-2678
Population attributable fraction of stroke incidence in middle-aged and elderly people: Contributions of hypertension, smoking and atrial fibrillation
Authors: Nakayama, T Yokoyama, T Yoshiike, N Zaman, MM Date, C Tanaka, H Detels, R
Citation: T. Nakayama et al., Population attributable fraction of stroke incidence in middle-aged and elderly people: Contributions of hypertension, smoking and atrial fibrillation, NEUROEPIDEM, 19(4), 2000, pp. 217-226
Antigen-specific production of RANTES, macrophage inflammatory protein (MIP)1 alpha, and MIP-1 beta in vitro is a correlate of reduced human immunodeficiency virus burden in vivo
Authors: Ferbas, J Giorgi, JV Amini, S Grovit-Ferbas, K Wiley, DJ Detels, R Plaeger, S
Citation: J. Ferbas et al., Antigen-specific production of RANTES, macrophage inflammatory protein (MIP)1 alpha, and MIP-1 beta in vitro is a correlate of reduced human immunodeficiency virus burden in vivo, J INFEC DIS, 182(4), 2000, pp. 1247-1250
Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men
Authors: Lyles, RH Munoz, A Yamashita, TE Bazmi, H Detels, R Rinaldo, CR Margolick, JB Phair, JP Mellors, JW
Citation: Rh. Lyles et al., Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men, J INFEC DIS, 181(3), 2000, pp. 872-880
Impact of potent antiretroviral therapy on the incidence of Kaposi's sarcoma and non-Hodgkin's lymphomas among HIV-1-infected individuals
Authors: Jacobson, LP Yamashita, TE Detels, R Margolick, JB Chmiel, JS Kingsley, LA Melnick, S Munoz, A
Citation: Lp. Jacobson et al., Impact of potent antiretroviral therapy on the incidence of Kaposi's sarcoma and non-Hodgkin's lymphomas among HIV-1-infected individuals, J ACQ IMM D, 21, 1999, pp. S34-S41
Aberrant expression of CD27 and soluble CD27 (sCD27) in HIV infection and in AIDS-associated lymphoma
Authors: Widney, D Gundapp, G Said, JW van der Meijden, M Bonavida, B Demidem, A Trevisan, C Taylor, J Detels, R Martinez-Maza, O
Citation: D. Widney et al., Aberrant expression of CD27 and soluble CD27 (sCD27) in HIV infection and in AIDS-associated lymphoma, CLIN IMMUNO, 93(2), 1999, pp. 114-123
Risultati: 1-25 | 26-35